Bangladesh Study Suggests that Ivermectin Combo can Treat COVID-19

The July issue of the&nbsp;Journal of Bangladesh College of Physicians and Surgeons&nbsp;includes, “A Case Series of 100 COVID-19 Positive Patients Treated with a Combination of Ivermectin and Doxycycline.” Given the studies showing Ivermectin can limit SARS-CoV-2 in the test tube, the researchers set out to see if this would translate to an effective medicine. The study looked at 100 patients, and the results were as follows: among patients aged 8 to 84 given the drug plus an antibiotic, retesting was done at 4 and 18 days of starting the medication. “All patients tested negative and their symptoms improved within 72 hours. There were no noticeable side effects.” The paper concludes that “Combination of Ivermectin and doxycycline was found to be very effective in viral clearance in mild and moderately sick COVID-19 patients. Medical societies and institutions should undertake larger multi center studies to validate and recommend this combination therapy to include in national guidelines.”


